Corticosteroids Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Global Corticosteroids Market Growth & Manufacturers. The market is segmented by Product type (Glucocorticoids, Mineralocorticoids), Route of Administration (Topical Steroids, Inhaled Steroids, Oral Forms, Systemic Forms), Application (Rheumatology Indications, Skin Allergies, Endocrinology, Gastroenterology, Acute Respiratory Diseases, Others), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The market values are provided in terms of (USD Million) for the above segments.

Corticosteroids Market Size

Single User License
Team License
Corporate License
Book before:
Corticosteroids Market snapshot
share button
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 4.30 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Global Corticosteroids Market

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

OFF

Team License

OFF

Corporate License

OFF
Book before:

Corticosteroids Market Analysis

The corticosteroid market is expected to witness a CAGR of 4.3% during the forecast period (2022-2027).

The COVID-19 pandemic has had a substantial influence on worldwide healthcare systems, as well as the market for corticosteroids. Early in the pandemic, epidemiological data showed that people with Chronic obstructive pulmonary disease (COPD) and asthma had a decreased rate of COVID-19 infection, leading to the suggestion that inhaled corticosteroids would help. In addition, in September 2020, the World Health Organization collaborated with investigators from seven corticosteroid trials to conduct a prospective meta-analysis of randomized trials for corticosteroid therapy for COVID-19 (PMA) to quickly provide additional evidence to complement the RECOVERY data and inform guidance development, according to a World Health Organization report due in September 2020. Moreover, according to the article published in BMC Infectious Disease in May 2021, in hospitalized hypoxic COVID-19 patients, methylprednisolone demonstrated better results compared to dexamethasone. As a result, the increased usage of corticosteroids in the treatment of COVID-19 patients demonstrates COVID-19's significant impact on the market.

The major factors accounting for the growth of the corticosteroid market are increasing the incidence of chronic diseases, the growing geriatric population, and surging investment in research and development. According to the United Nations report 2020, the estimated human population is expected to increase from 7.2 billion today to 8.2 billion by 2025. This, in turn, raises the global burden of chronic diseases to 57 percent by the end of 2020. According to the Centers for Disease Control and Prevention 2020 report, in the United States, approximately 25 million Americans have asthma. This equals to about 1 in 13 Americans, including 8% of adults and 7% of children. About 20 million United States adults aged 18 years and over have asthma. Corticosteroids are majorly used in the treatment of asthma, and the rising prevalence of it boosts the market growth over the forecast period.

Furthermore, according to the World Ageing 2020 report, in 2020, there were around 727 million people aged 65 years or more in the world. The number of older persons is projected to double to 1.5 billion in 2050. the geriatric population is more prone to chronic diseases which require corticosteroid therapy for various diseases that will help grow the market in the years to come.

Hence, this uninterrupted incidence and prevalence of chronic diseases lead to the growth of the Corticosteroids market during the forecast period. However, the risk factors associated with the prolonged use of corticosteroids hampers the growth of the market to some extent.

Corticosteroids Market Trends

This section covers the major market trends shaping the Corticosteroids Market according to our research experts:

Topical Steroids segment by Route of Administration Dominates the Market During the Forecast Period

Topical corticosteroids are a type of steroid medicine applied directly to the skin to reduce inflammation and irritation. Topical corticosteroids are available in several different forms, including creams, lotions, and gels.

Topical steroids are used in treating the skin conditions such as rash, dermatitis, itching, eczema, and psoriasis, and this segment is expected to dominate the market due to the continuous growth of the geriatric population with rising skin diseases around the world and the extended storage capacity of the topical corticosteroids.

As aging results in the decline of the normal functioning of organ systems, including skin, the geriatric population is highly prone to skin diseases. According to the data from World Population Prospects 2022, the share of the global population aged 65 years or above is projected to rise from 10 per cent in 2022 to 16 per cent in 2050. By 2050, the number of persons aged 65 years or over worldwide is projected to be more than twice the number of children under age 5 and about the same as the number of children under age 12. In terms of convenience, the geriatric population with skin diseases prefers to use topical steroids.  

All these factors together support that Topical steroids dominate the corticosteroids market.

Corticosteroids market

North America Dominates the Market and the Same is Expected Over the Forecast Period.

North America is expected to dominate the overall market throughout the forecast period, which is attributed to the developed economy, increasing health care expenditure, increasing incidence of lifestyle-related diseases, and high adoption of technologically advanced products in the region.

According to the Globocan 2020 report, an estimated 2,281,658 new cancer cases were diagnosed in the United States in 2020. In 2020, The most common cancers were breast (253,465), lung (227,875), prostate (209,512), and colon (101,809) in the United States. Furthermore, According to the Centers for Disease Control and Prevention 2020 report, in the United States, approximately 25 million Americans have asthma. This equals to about 1 in 13 Americans, including 8% of adults and 7% of children. About 20 million United States adults aged 18 years and over have asthma. Also, according to the Asthma and Allergy Foundation of America (AAFA), in 2021, roughly 1 in 13 Americans had asthma, which is about 25 million people. As per the same source, about 5 million American children have asthma which strongly supports North America to dominate the market during the forecast period.

Furthermore, in the United States, asthma is more common in adult women than in adult men. According to the Centers for Disease Control and Prevention 2020 report, in the United States, approximately 25 million Americans have asthma. This equals to about 1 in 13 Americans, including 8% of adults and 7% of children. About 20 million United States adults age 18 and over have asthma. Similarly, asthma is a major public health concern in Canada. As a lifelong respiratory illness, asthma affects the work productivity, quality of life, mental health, and psychological well-being of the Canadian population. 

Thus, the increasing prevalence of asthma is expected to raise the demand for corticosteroids, thereby boosting the market in the region.

Corticosteroids_Geography

Corticosteroids Industry Overview

The corticosteroid market is moderately competitive and consists of several major players. With the increasing consolidations of various organizations in the healthcare sector, it is expected to generate competitive rivalry among the key players in the future. Some of the major players in the market are Pfizer Inc., Novartis, AstraZeneca, GSK, Cipla Inc., Merck, etc.,

Corticosteroids Market Leaders

  1. Pfizer Inc.

  2. Novartis

  3. GSK

  4. Merck

  5. AstraZeneca

*Disclaimer: Major Players sorted in no particular order

corticosteroids market
bookmark Need More Details on Market Players and Competitors?
Download PDF

Corticosteroids Market News

  • In April 2022, Lilly's lebrikizumab combined with topical corticosteroids showed significant improvements in disease severity for atopic dermatitis
  • In August 2022, the first patient was been dosed in a pilot study evaluating vamorolone as a potential treatment for Becker muscular dystrophy (BMD). The steroid medication has been under development by ReveraGen BioPharma as a possible therapy for other types of muscular dystrophy.

Corticosteroids Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Geriatric Population and Increasing Incidence of Chronic Diseases

      2. 4.2.2 Surging investment in Research and Development

    3. 4.3 Market Restraints

      1. 4.3.1 Pricing Pressure on the Companies by the Government

      2. 4.3.2 Risk factors associated with Corticosteriods on Prolonged use

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Product

      1. 5.1.1 Glucocorticoids

      2. 5.1.2 Mineralocorticoids

    2. 5.2 By Route of administration

      1. 5.2.1 Topical steroids

      2. 5.2.2 Inhaled steroids

      3. 5.2.3 Oral forms

      4. 5.2.4 Systemic forms

      5. 5.2.5 Others

    3. 5.3 By Application

      1. 5.3.1 Rheumatology indications

      2. 5.3.2 Skin allergies

      3. 5.3.3 Endocrinology

      4. 5.3.4 Gastroenterology

      5. 5.3.5 Acute respiratory diseases

      6. 5.3.6 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Pfizer Inc.

      2. 6.1.2 Novartis AG

      3. 6.1.3 Sanofi S.A.

      4. 6.1.4 GlaxoSmithKline plc

      5. 6.1.5 Cipla Inc.

      6. 6.1.6 Johnson & Johnson Services, Inc.

      7. 6.1.7 AstraZeneca plc

      8. 6.1.8 Merck & Co., Inc.,

      9. 6.1.9 Sumitomo Corporation

      10. 6.1.10 Leo Pharma

      11. 6.1.11 Bayer Pharmaceutical

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
bookmark You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Corticosteroids Industry Segmentation

Corticosteroids are the steroid hormones that are either produced by the body (Systemic corticosteroids) or man-made (Synthetic corticosteroids). When the adrenal cortex ceases the production of required corticosteroids, synthetic corticosteroids are given to the patients. They are often used as part of treatment for different diseases like asthma, various skin allergies, and arthritis, among others. The corticosteroids market is segmented by Product type (Glucocorticoids, Mineralocorticoids), Route of Administration (Topical steroids, Inhaled steroids, Oral forms, Systemic forms), Application (Rheumatology indications, Skin allergies, Endocrinology, Gastroenterology, Acute respiratory diseases, Others), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product
Glucocorticoids
Mineralocorticoids
By Route of administration
Topical steroids
Inhaled steroids
Oral forms
Systemic forms
Others
By Application
Rheumatology indications
Skin allergies
Endocrinology
Gastroenterology
Acute respiratory diseases
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
customize-icon Need A Different Region Or Segment?
Customize Now

Corticosteroids Market Research FAQs

The Global Corticosteroids Market is projected to register a CAGR of 4.30% during the forecast period (2024-2029)

Pfizer Inc. , Novartis, GSK, Merck and AstraZeneca are the major companies operating in the Global Corticosteroids Market.

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in Global Corticosteroids Market.

The report covers the Global Corticosteroids Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Corticosteroids Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Corticosteroids Industry Report

Statistics for the 2024 Corticosteroids market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Corticosteroids analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Corticosteroids Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)